Royalty Pharma RPRX Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Royalty Pharma in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Royalty Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Royalty Pharma's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Royalty Pharma's operating cash flow?
- Royalty Pharma (RPRX) reported operating cash flow of $718.23M in Q1 2026.
- How has Royalty Pharma's operating cash flow changed year-over-year?
- Royalty Pharma's operating cash flow increased by 20.5% year-over-year, from $596.08M to $718.23M.
- What is the long-term trend for Royalty Pharma's operating cash flow?
- Over 4 years (2021 to 2025), Royalty Pharma's operating cash flow has grown at a 5.4% compound annual growth rate (CAGR), from $2.02B to $2.49B.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.